Premium
BioLife Solutions Inc (BLFS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -515,00 | 9,92k | Sale to Issuer | 19,27 | 390,17k | -0,13% |
| 2026-04-08 | Mr. Todd BerardChief Commercial Officer | -293,00 | 5,65k | Sale to Issuer | 19,27 | 163,77k | -0,18% |
| 2026-04-08 | Mr. Troy WichtermanCFO | -844,00 | 16,26k | Sale to Issuer | 19,27 | 216,06k | -0,39% |
| 2026-03-23 | Ms. Karen FosterInitié | -2,58k | 49,40k | Automatic Disposition | 19,17 | 108,76k | -2,31% |
| 2026-03-19 | Mr. Roderick de GreefCEO & Chairman | -11,10k | 212,25k | Sale to Issuer | 19,12 | 357,64k | -3,01% |
| 2026-03-19 | Ms. Karen FosterInitié | -1,91k | 36,46k | Sale to Issuer | 19,12 | 111,34k | -1,68% |
| 2026-03-19 | Ms. Sarah AebersoldInitié | -931,00 | 17,80k | Sale to Issuer | 19,12 | 92,43k | -1,00% |
| 2026-03-19 | Mr. Sean WernerCTO | -1,68k | 32,14k | Sale to Issuer | 19,12 | 48,25k | -3,37% |
| 2026-03-19 | Mr. Troy WichtermanCFO | -3,75k | 71,68k | Sale to Issuer | 19,12 | 216,90k | -1,70% |
| 2026-03-19 | Mr. Todd BerardChief Commercial Officer | -1,88k | 35,93k | Sale to Issuer | 19,12 | 164,06k | -1,13% |
| 2026-03-19 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -2,26k | 43,12k | Sale to Issuer | 19,12 | 390,68k | -0,57% |
| 2026-03-05 | Ms. Karen FosterInitié | -97,42k | 1,96M | Vente | 20,00 - 20,15 | 113,24k | -46,25% |
| 2026-03-03 | Mr. Sean WernerCTO | -111,00 | 2,30k | Automatic Disposition | 20,74 | 49,93k | -0,22% |
| 2026-03-03 | Ms. Sarah AebersoldInitié | -219,00 | 4,54k | Automatic Disposition | 20,74 | 93,36k | -0,23% |
| 2026-03-03 | Mr. Todd BerardChief Commercial Officer | -353,00 | 7,32k | Automatic Disposition | 20,74 | 165,94k | -0,21% |
| 2026-03-03 | Mr. Troy WichtermanCFO | -588,00 | 12,20k | Automatic Disposition | 20,74 | 220,65k | -0,27% |
| 2026-03-03 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -529,00 | 10,97k | Automatic Disposition | 20,74 | 392,94k | -0,13% |
| 2026-03-03 | Ms. Karen FosterInitié | -418,00 | 8,67k | Automatic Disposition | 20,74 | 210,67k | -0,20% |
| 2026-02-24 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -15,59k | 353,00k | Sale to Issuer | 22,65 | 393,47k | -3,81% |
| 2026-02-24 | Mr. Troy WichtermanCFO | -25,53k | 578,14k | Sale to Issuer | 22,65 | 221,24k | -10,34% |
| 2026-02-24 | Mr. Todd BerardChief Commercial Officer | -8,85k | 200,36k | Sale to Issuer | 22,65 | 166,29k | -5,05% |
| 2026-02-24 | Mr. Roderick de GreefCEO & Chairman | -153,20k | 3,47M | Sale to Issuer | 22,65 | 459,26k | -25,01% |
| 2026-02-24 | Ms. Karen FosterInitié | -13,01k | 294,74k | Sale to Issuer | 22,65 | 211,08k | -5,81% |
| 2026-02-24 | Ms. Sarah AebersoldInitié | -5,73k | 129,88k | Sale to Issuer | 22,65 | 93,58k | -5,77% |
| 2026-01-06 | Mr. Troy WichtermanCFO | -990,00 | 25,33k | Automatic Disposition | 25,59 | 150,75k | -0,65% |
| 2026-01-06 | Mr. Todd BerardChief Commercial Officer | -344,00 | 8,80k | Automatic Disposition | 25,59 | 132,56k | -0,26% |
| 2026-01-06 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -405,00 | 10,36k | Automatic Disposition | 25,59 | 349,35k | -0,12% |
| 2026-01-06 | Ms. Sarah AebersoldInitié | -241,00 | 6,17k | Automatic Disposition | 25,59 | 75,77k | -0,32% |
| 2026-01-06 | Ms. Karen FosterInitié | -335,00 | 8,57k | Automatic Disposition | 25,59 | 191,98k | -0,17% |
| 2025-12-09 | Ms. Karen FosterInitié | -519,00 | 13,04k | Automatic Disposition | 25,13 | 192,32k | -0,27% |
| 2025-12-09 | Mr. Todd BerardChief Commercial Officer | -358,00 | 9,00k | Automatic Disposition | 25,13 | 132,91k | -0,27% |
| 2025-12-15 | Ms. Amy DuRossIndependent Lead Director | -2,00k | 49,20k | Vente | 24,60 | 18,69k | -9,67% |
| 2025-12-15 | Ms. Sarah AebersoldInitié | -713,00 | 17,44k | Vente | 24,46 | 76,01k | -0,93% |
| 2025-12-09 | Ms. Sarah AebersoldInitié | -233,00 | 5,86k | Automatic Disposition | 25,13 | 76,01k | -0,31% |
| 2025-12-09 | Mr. Troy WichtermanCFO | -1,03k | 25,96k | Automatic Disposition | 25,13 | 151,74k | -0,68% |
| 2025-12-09 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -631,00 | 15,86k | Automatic Disposition | 25,13 | 349,76k | -0,18% |
| 2025-12-04 | Mr. Troy WichtermanCFO | -30,00k | 771,60k | Vente | 25,72 | 152,77k | -16,41% |
| 2025-11-25 | Ms. Amy DuRossIndependent Lead Director | -4,00k | 108,00k | Vente | 27,00 | 20,69k | -16,20% |
| 2025-11-25 | Ms. Sarah AebersoldInitié | -217,00 | 5,80k | Automatic Disposition | 26,74 | 76,95k | -0,28% |
| 2025-11-25 | Mr. Troy WichtermanCFO | -584,00 | 15,62k | Automatic Disposition | 26,74 | 182,77k | -0,32% |
| 2025-11-25 | Mr. Todd BerardChief Commercial Officer | -351,00 | 9,39k | Automatic Disposition | 26,74 | 133,27k | -0,26% |
| 2025-11-25 | Mr. Sean WernerCTO | -110,00 | 2,94k | Automatic Disposition | 26,74 | 25,93k | -0,42% |
| 2025-11-25 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -526,00 | 14,07k | Automatic Disposition | 26,74 | 350,39k | -0,15% |
| 2025-11-25 | Ms. Karen FosterInitié | -415,00 | 11,10k | Automatic Disposition | 26,74 | 192,84k | -0,21% |
| 2025-11-19 | Ms. Amy DuRossIndependent Lead Director | -6,00k | 148,55k | Vente | 24,50 - 26,00 | 24,69k | -19,55% |
| 2025-11-11 | Mr. Roderick de GreefCEO & Chairman | -100,00k | 2,58M | Vente | 25,33 - 26,15 | 79,74k | -55,64% |
| 2025-10-24 | Dr. Joydeep GoswamiIndependent Director | -1,67k | 48,30k | Automatic Disposition | 28,99 | 44,99k | -3,57% |
| 2025-10-22 | Mr. Roderick de GreefCEO & Chairman | -37,80k | 1,03M | Automatic Disposition | 27,30 | 179,74k | -17,37% |
| 2025-10-20 | Mr. Sean WernerCTO | -275,00 | 7,65k | Automatic Disposition | 27,82 | 26,04k | -1,05% |
| 2025-10-16 | Dr. Joydeep GoswamiIndependent Director | -1,33k | 0,00 | Automatic Disposition | - | 46,65k | -2,78% |
| 2025-10-15 | Casdin Capital, LLCSociété | -750,00k | 21,41M | Vente | 28,55 | 5,96M | -11,18% |
| 2025-10-09 | Mr. Troy WichtermanCFO | -833,00 | 22,79k | Automatic Disposition | 27,36 | 183,35k | -0,45% |
| 2025-10-09 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -509,00 | 13,93k | Automatic Disposition | 27,36 | 350,91k | -0,14% |
| 2025-10-09 | Mr. Todd BerardChief Commercial Officer | -289,00 | 7,91k | Automatic Disposition | 27,36 | 133,62k | -0,22% |
| 2025-10-09 | Ms. Karen FosterInitié | -419,00 | 11,46k | Automatic Disposition | 27,36 | 193,25k | -0,22% |
| 2025-10-09 | Ms. Sarah AebersoldInitié | -188,00 | 5,14k | Automatic Disposition | 27,36 | 77,17k | -0,24% |
| 2025-09-15 | Ms. Sarah AebersoldInitié | -714,00 | 18,29k | Automatic Disposition | 25,61 | 77,36k | -0,91% |
| 2025-09-11 | Mr. Todd BerardChief Commercial Officer | -358,00 | 9,61k | Automatic Disposition | 26,83 | 133,91k | -0,27% |
| 2025-09-11 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -630,00 | 16,90k | Automatic Disposition | 26,83 | 351,42k | -0,18% |
| 2025-09-11 | Ms. Karen FosterInitié | -511,00 | 13,71k | Automatic Disposition | 26,83 | 193,67k | -0,26% |
| 2025-09-11 | Ms. Sarah AebersoldInitié | -233,00 | 6,25k | Automatic Disposition | 26,83 | 78,07k | -0,30% |
| 2025-09-11 | Mr. Sean WernerCTO | -72,00 | 1,93k | Automatic Disposition | 26,83 | 26,31k | -0,27% |
| 2025-09-11 | Mr. Troy WichtermanCFO | -1,03k | 27,69k | Automatic Disposition | 26,83 | 184,19k | -0,56% |
| 2025-08-26 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -531,00 | 13,51k | Automatic Disposition | 25,44 | 352,05k | -0,15% |
| 2025-08-26 | Ms. Sarah AebersoldInitié | -219,00 | 5,57k | Automatic Disposition | 25,44 | 78,30k | -0,28% |
| 2025-08-26 | Mr. Troy WichtermanCFO | -590,00 | 15,01k | Automatic Disposition | 25,44 | 185,22k | -0,32% |
| 2025-08-26 | Mr. Sean WernerCTO | -111,00 | 2,82k | Automatic Disposition | 25,44 | 26,38k | -0,42% |
| 2025-08-26 | Ms. Karen FosterInitié | -413,00 | 10,51k | Automatic Disposition | 25,44 | 194,18k | -0,21% |
| 2025-08-26 | Mr. Todd BerardChief Commercial Officer | -354,00 | 9,01k | Automatic Disposition | 25,44 | 134,26k | -0,26% |
| 2025-08-25 | Mr. Todd BerardChief Commercial Officer | -10,00k | 255,30k | Vente | 25,53 | 124,62k | -7,43% |
| 2025-08-15 | Casdin Capital, LLCSociété | -500,00k | 12,20M | Vente | 24,40 | 6,71M | -6,94% |
| 2025-08-11 | Casdin Capital, LLCSociété | -500,00k | 11,30M | Vente | 22,60 | 7,21M | -6,49% |
| 2025-07-18 | Mr. Sean WernerCTO | -1,12k | 23,66k | Automatic Disposition | 21,22 | 26,50k | -4,04% |
| 2025-07-07 | Ms. Karen FosterInitié | -400,00 | 8,91k | Automatic Disposition | 22,27 | 194,60k | -0,21% |
| 2025-07-07 | Ms. Sarah AebersoldInitié | -198,00 | 4,41k | Automatic Disposition | 22,27 | 78,52k | -0,25% |
| 2025-07-07 | Mr. Todd BerardChief Commercial Officer | -304,00 | 6,77k | Automatic Disposition | 22,27 | 134,62k | -0,23% |
| 2025-07-07 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -536,00 | 11,94k | Automatic Disposition | 22,27 | 352,58k | -0,15% |
| 2025-07-07 | Mr. Troy WichtermanCFO | -877,00 | 19,53k | Automatic Disposition | 22,27 | 185,81k | -0,47% |
| 2025-06-16 | Ms. Sarah AebersoldInitié | -711,00 | 15,81k | Automatic Disposition | 22,23 | 78,72k | -0,90% |
| 2025-06-10 | Casdin Capital, LLCSociété | -1 000,00k | 23,80M | Vente | 23,80 | 7,71M | -11,48% |
| 2025-06-10 | Mr. Todd BerardChief Commercial Officer | -362,00 | 8,58k | Automatic Disposition | 23,70 | 134,92k | -0,27% |
| 2025-06-10 | Ms. Karen FosterInitié | -320,00 | 7,58k | Automatic Disposition | 23,70 | 195,00k | -0,16% |
| 2025-06-10 | Ms. Sarah AebersoldInitié | -235,00 | 5,57k | Automatic Disposition | 23,70 | 79,43k | -0,29% |
| 2025-06-10 | Mr. Sean WernerCTO | -65,00 | 1,54k | Automatic Disposition | 23,70 | 27,61k | -0,23% |
| 2025-06-10 | Mr. Troy WichtermanCFO | -1,04k | 24,70k | Automatic Disposition | 23,70 | 186,69k | -0,56% |
| 2025-06-10 | Dr. Aby J. MathewChairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer | -637,00 | 15,10k | Automatic Disposition | 23,70 | 353,12k | -0,18% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
